Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for Hematology Quality Controls was estimated to be worth US$ 537 million in 2025 and is projected to reach US$ 813 million, growing at a CAGR of 6.2% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hematology Quality Controls cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Hematology Quality Controls Market Size(US$)
M= millions and B=billions

Hematology Quality Controls are specialized quality control substances used to monitor the stability of the detection process of blood analyzers (such as blood routine testing equipment) and evaluate the performance of the detection system. Its core goal is to ensure that the blood analyzer provides accurate, reliable, and reproducible test results for patient samples at different times, batches of reagents, or operating conditions. It is one of the core tools of the quality management system for blood testing laboratories.
The North American market for Hematology Quality Controls was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Hematology Quality Controls was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Hematology Quality Controls was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Hematology Quality Controls market include Bio-Rad, Streck, Thermo Fisher Scientific, Randox Laboratories, Sysmex, Fortress Diagnostics, Bio-Techne, Diatron, Changchun DIRUI, Shenzhen Mindray, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Hematology Quality Controls, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Hematology Quality Controls market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Hematology Quality Controls.
Market Segmentation
Report Metric
Details
Report Title
Hematology Quality Controls- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Forecasted Market Size in 2032
US$ 813 million
CAGR(2026-2032)
6.2%
Market Size Available for Years
2026-2032
Global Hematology Quality Controls Companies Covered
Bio-Rad
Streck
Thermo Fisher Scientific
Randox Laboratories
Sysmex
Fortress Diagnostics
Bio-Techne
Diatron
Changchun DIRUI
Shenzhen Mindray
Sichuan ZCMT
Global Hematology Quality Controls Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hematology Quality Controls Market, Segment by Type
High Level
Medium Level
Low Level
Global Hematology Quality Controls Market, Segment by Application
Hospital
Laboratory
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Hematology Quality Controls manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Hematology Quality Controls sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Hematology Quality Controls sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Hematology Quality Controls Product Introduction
1.2 Global Hematology Quality Controls Market Size Forecast
1.2.1 Global Hematology Quality Controls Sales Value (2021–2032)
1.2.2 Global Hematology Quality Controls Sales Volume (2021–2032)
1.2.3 Global Hematology Quality Controls Sales Price (2021–2032)
1.3 Hematology Quality Controls Market Trends & Drivers
1.3.1 Hematology Quality Controls Industry Trends
1.3.2 Hematology Quality Controls Market Drivers & Opportunities
1.3.3 Hematology Quality Controls Market Challenges
1.3.4 Hematology Quality Controls Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hematology Quality Controls Players Revenue Ranking (2025)
2.2 Global Hematology Quality Controls Revenue by Company (2021–2026)
2.3 Global Hematology Quality Controls Sales Volume Ranking of Players (2025)
2.4 Global Hematology Quality Controls Sales Volume by Company (2021–2026)
2.5 Global Hematology Quality Controls Average Price by Company (2021–2026)
2.6 Key Manufacturers Hematology Quality Controls Manufacturing Base and Headquarters
2.7 Key Manufacturers Hematology Quality Controls Product Offerings
2.8 Key Manufacturers Start of Mass Production of Hematology Quality Controls
2.9 Hematology Quality Controls Market Competitive Analysis
2.9.1 Hematology Quality Controls Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Hematology Quality Controls Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hematology Quality Controls revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Hematology Quality Controls Market Classification
3.1 Introduction by Type
3.1.1 High Level
3.1.2 Medium Level
3.1.3 Low Level
3.1.4 Global Hematology Quality Controls Sales Value by Type
3.1.4.1 Global Hematology Quality Controls Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Hematology Quality Controls Sales Value, by Type (2021–2032)
3.1.4.3 Global Hematology Quality Controls Sales Value, by Type (%), 2021–2032
3.1.5 Global Hematology Quality Controls Sales Volume by Type
3.1.5.1 Global Hematology Quality Controls Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Hematology Quality Controls Sales Volume, by Type (2021–2032)
3.1.5.3 Global Hematology Quality Controls Sales Volume, by Type (%), 2021–2032
3.1.6 Global Hematology Quality Controls Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Laboratory
4.2 Global Hematology Quality Controls Sales Value by Application
4.2.1 Global Hematology Quality Controls Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Hematology Quality Controls Sales Value, by Application (2021–2032)
4.2.3 Global Hematology Quality Controls Sales Value, by Application (%), 2021–2032
4.3 Global Hematology Quality Controls Sales Volume by Application
4.3.1 Global Hematology Quality Controls Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Hematology Quality Controls Sales Volume, by Application (2021–2032)
4.3.3 Global Hematology Quality Controls Sales Volume, by Application (%), 2021–2032
4.4 Global Hematology Quality Controls Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Hematology Quality Controls Sales Value by Region
5.1.1 Global Hematology Quality Controls Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Hematology Quality Controls Sales Value by Region (2021–2026)
5.1.3 Global Hematology Quality Controls Sales Value by Region (2027–2032)
5.1.4 Global Hematology Quality Controls Sales Value by Region (%), 2021–2032
5.2 Global Hematology Quality Controls Sales Volume by Region
5.2.1 Global Hematology Quality Controls Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Hematology Quality Controls Sales Volume by Region (2021–2026)
5.2.3 Global Hematology Quality Controls Sales Volume by Region (2027–2032)
5.2.4 Global Hematology Quality Controls Sales Volume by Region (%), 2021–2032
5.3 Global Hematology Quality Controls Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Hematology Quality Controls Sales Value, 2021–2032
5.4.2 North America Hematology Quality Controls Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Hematology Quality Controls Sales Value, 2021–2032
5.5.2 Europe Hematology Quality Controls Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Hematology Quality Controls Sales Value, 2021–2032
5.6.2 Asia Pacific Hematology Quality Controls Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Hematology Quality Controls Sales Value, 2021–2032
5.7.2 South America Hematology Quality Controls Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hematology Quality Controls Sales Value, 2021–2032
5.8.2 Middle East & Africa Hematology Quality Controls Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hematology Quality Controls Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Hematology Quality Controls Sales Value and Sales Volume
6.2.1 Key Countries/Regions Hematology Quality Controls Sales Value, 2021–2032
6.2.2 Key Countries/Regions Hematology Quality Controls Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Hematology Quality Controls Sales Value, 2021–2032
6.3.2 United States Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Hematology Quality Controls Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Hematology Quality Controls Sales Value, 2021–2032
6.4.2 Europe Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Hematology Quality Controls Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Hematology Quality Controls Sales Value, 2021–2032
6.5.2 China Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
6.5.3 China Hematology Quality Controls Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Hematology Quality Controls Sales Value, 2021–2032
6.6.2 Japan Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Hematology Quality Controls Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Hematology Quality Controls Sales Value, 2021–2032
6.7.2 South Korea Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Hematology Quality Controls Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Hematology Quality Controls Sales Value, 2021–2032
6.8.2 Southeast Asia Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Hematology Quality Controls Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Hematology Quality Controls Sales Value, 2021–2032
6.9.2 India Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
6.9.3 India Hematology Quality Controls Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Bio-Rad
7.1.1 Bio-Rad Company Information
7.1.2 Bio-Rad Introduction and Business Overview
7.1.3 Bio-Rad Hematology Quality Controls Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Bio-Rad Hematology Quality Controls Product Offerings
7.1.5 Bio-Rad Recent Developments
7.2 Streck
7.2.1 Streck Company Information
7.2.2 Streck Introduction and Business Overview
7.2.3 Streck Hematology Quality Controls Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Streck Hematology Quality Controls Product Offerings
7.2.5 Streck Recent Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Information
7.3.2 Thermo Fisher Scientific Introduction and Business Overview
7.3.3 Thermo Fisher Scientific Hematology Quality Controls Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Thermo Fisher Scientific Hematology Quality Controls Product Offerings
7.3.5 Thermo Fisher Scientific Recent Developments
7.4 Randox Laboratories
7.4.1 Randox Laboratories Company Information
7.4.2 Randox Laboratories Introduction and Business Overview
7.4.3 Randox Laboratories Hematology Quality Controls Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Randox Laboratories Hematology Quality Controls Product Offerings
7.4.5 Randox Laboratories Recent Developments
7.5 Sysmex
7.5.1 Sysmex Company Information
7.5.2 Sysmex Introduction and Business Overview
7.5.3 Sysmex Hematology Quality Controls Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Sysmex Hematology Quality Controls Product Offerings
7.5.5 Sysmex Recent Developments
7.6 Fortress Diagnostics
7.6.1 Fortress Diagnostics Company Information
7.6.2 Fortress Diagnostics Introduction and Business Overview
7.6.3 Fortress Diagnostics Hematology Quality Controls Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Fortress Diagnostics Hematology Quality Controls Product Offerings
7.6.5 Fortress Diagnostics Recent Developments
7.7 Bio-Techne
7.7.1 Bio-Techne Company Information
7.7.2 Bio-Techne Introduction and Business Overview
7.7.3 Bio-Techne Hematology Quality Controls Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Bio-Techne Hematology Quality Controls Product Offerings
7.7.5 Bio-Techne Recent Developments
7.8 Diatron
7.8.1 Diatron Company Information
7.8.2 Diatron Introduction and Business Overview
7.8.3 Diatron Hematology Quality Controls Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Diatron Hematology Quality Controls Product Offerings
7.8.5 Diatron Recent Developments
7.9 Changchun DIRUI
7.9.1 Changchun DIRUI Company Information
7.9.2 Changchun DIRUI Introduction and Business Overview
7.9.3 Changchun DIRUI Hematology Quality Controls Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Changchun DIRUI Hematology Quality Controls Product Offerings
7.9.5 Changchun DIRUI Recent Developments
7.10 Shenzhen Mindray
7.10.1 Shenzhen Mindray Company Information
7.10.2 Shenzhen Mindray Introduction and Business Overview
7.10.3 Shenzhen Mindray Hematology Quality Controls Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Shenzhen Mindray Hematology Quality Controls Product Offerings
7.10.5 Shenzhen Mindray Recent Developments
7.11 Sichuan ZCMT
7.11.1 Sichuan ZCMT Company Information
7.11.2 Sichuan ZCMT Introduction and Business Overview
7.11.3 Sichuan ZCMT Hematology Quality Controls Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Sichuan ZCMT Hematology Quality Controls Product Offerings
7.11.5 Sichuan ZCMT Recent Developments
8 Industry Chain Analysis
8.1 Hematology Quality Controls Industrial Chain
8.2 Hematology Quality Controls Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Hematology Quality Controls Sales Model
8.5.2 Sales Channels
8.5.3 Hematology Quality Controls Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Hematology Quality Controls Market Trends
Table 2. Hematology Quality Controls Market Drivers & Opportunities
Table 3. Hematology Quality Controls Market Challenges
Table 4. Hematology Quality Controls Market Restraints
Table 5. Global Hematology Quality Controls Revenue by Company (US$ Million), 2021–2026
Table 6. Global Hematology Quality Controls Revenue Market Share by Company (2021–2026)
Table 7. Global Hematology Quality Controls Sales Volume by Company (K Units), 2021–2026
Table 8. Global Hematology Quality Controls Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Hematology Quality Controls Price by Company (US$/Unit), 2021–2026
Table 10. Key Manufacturers Hematology Quality Controls Manufacturing Base and Headquarters
Table 11. Key Manufacturers Hematology Quality Controls Product Type
Table 12. Key Manufacturers Start of Mass Production of Hematology Quality Controls
Table 13. Global Hematology Quality Controls Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Hematology Quality Controls revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Hematology Quality Controls Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Hematology Quality Controls Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Hematology Quality Controls Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Hematology Quality Controls Sales Market Share in Value by Type (2021–2026)
Table 20. Global Hematology Quality Controls Sales Market Share in Value by Type (2027–2032)
Table 21. Global Hematology Quality Controls Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Hematology Quality Controls Sales Volume by Type (K Units), 2021–2026
Table 23. Global Hematology Quality Controls Sales Volume by Type (K Units), 2027–2032
Table 24. Global Hematology Quality Controls Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Hematology Quality Controls Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Hematology Quality Controls Price by Type (US$/Unit), 2021–2026
Table 27. Global Hematology Quality Controls Price by Type (US$/Unit), 2027–2032
Table 28. Global Hematology Quality Controls Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Hematology Quality Controls Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Hematology Quality Controls Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Hematology Quality Controls Sales Market Share in Value by Application (2021–2026)
Table 32. Global Hematology Quality Controls Sales Market Share in Value by Application (2027–2032)
Table 33. Global Hematology Quality Controls Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)
Table 34. Global Hematology Quality Controls Sales Volume by Application (K Units), 2021–2026
Table 35. Global Hematology Quality Controls Sales Volume by Application (K Units), 2027–2032
Table 36. Global Hematology Quality Controls Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Hematology Quality Controls Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Hematology Quality Controls Price by Application (US$/Unit), 2021–2026
Table 39. Global Hematology Quality Controls Price by Application (US$/Unit), 2027–2032
Table 40. Global Hematology Quality Controls Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Hematology Quality Controls Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Hematology Quality Controls Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Hematology Quality Controls Sales Value by Region (%), 2021–2026
Table 44. Global Hematology Quality Controls Sales Value by Region (%), 2027–2032
Table 45. Global Hematology Quality Controls Sales Volume by Region (K Units): 2021 vs 2025 vs 2032
Table 46. Global Hematology Quality Controls Sales Volume by Region (K Units), 2021–2026
Table 47. Global Hematology Quality Controls Sales Volume by Region (K Units), 2027–2032
Table 48. Global Hematology Quality Controls Sales Volume by Region (%), 2021–2026
Table 49. Global Hematology Quality Controls Sales Volume by Region (%), 2027–2032
Table 50. Global Hematology Quality Controls Average Price by Region (US$/Unit), 2021–2026
Table 51. Global Hematology Quality Controls Average Price by Region (US$/Unit), 2027–2032
Table 52. Key Countries/Regions Hematology Quality Controls Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Hematology Quality Controls Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Hematology Quality Controls Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Hematology Quality Controls Sales Volume, (K Units), 2021–2026
Table 56. Key Countries/Regions Hematology Quality Controls Sales Volume, (K Units), 2027–2032
Table 57. Bio-Rad Company Information
Table 58. Bio-Rad Introduction and Business Overview
Table 59. Bio-Rad Hematology Quality Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 60. Bio-Rad Hematology Quality Controls Product Offerings
Table 61. Bio-Rad Recent Developments
Table 62. Streck Company Information
Table 63. Streck Introduction and Business Overview
Table 64. Streck Hematology Quality Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 65. Streck Hematology Quality Controls Product Offerings
Table 66. Streck Recent Developments
Table 67. Thermo Fisher Scientific Company Information
Table 68. Thermo Fisher Scientific Introduction and Business Overview
Table 69. Thermo Fisher Scientific Hematology Quality Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 70. Thermo Fisher Scientific Hematology Quality Controls Product Offerings
Table 71. Thermo Fisher Scientific Recent Developments
Table 72. Randox Laboratories Company Information
Table 73. Randox Laboratories Introduction and Business Overview
Table 74. Randox Laboratories Hematology Quality Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 75. Randox Laboratories Hematology Quality Controls Product Offerings
Table 76. Randox Laboratories Recent Developments
Table 77. Sysmex Company Information
Table 78. Sysmex Introduction and Business Overview
Table 79. Sysmex Hematology Quality Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 80. Sysmex Hematology Quality Controls Product Offerings
Table 81. Sysmex Recent Developments
Table 82. Fortress Diagnostics Company Information
Table 83. Fortress Diagnostics Introduction and Business Overview
Table 84. Fortress Diagnostics Hematology Quality Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 85. Fortress Diagnostics Hematology Quality Controls Product Offerings
Table 86. Fortress Diagnostics Recent Developments
Table 87. Bio-Techne Company Information
Table 88. Bio-Techne Introduction and Business Overview
Table 89. Bio-Techne Hematology Quality Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 90. Bio-Techne Hematology Quality Controls Product Offerings
Table 91. Bio-Techne Recent Developments
Table 92. Diatron Company Information
Table 93. Diatron Introduction and Business Overview
Table 94. Diatron Hematology Quality Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 95. Diatron Hematology Quality Controls Product Offerings
Table 96. Diatron Recent Developments
Table 97. Changchun DIRUI Company Information
Table 98. Changchun DIRUI Introduction and Business Overview
Table 99. Changchun DIRUI Hematology Quality Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 100. Changchun DIRUI Hematology Quality Controls Product Offerings
Table 101. Changchun DIRUI Recent Developments
Table 102. Shenzhen Mindray Company Information
Table 103. Shenzhen Mindray Introduction and Business Overview
Table 104. Shenzhen Mindray Hematology Quality Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 105. Shenzhen Mindray Hematology Quality Controls Product Offerings
Table 106. Shenzhen Mindray Recent Developments
Table 107. Sichuan ZCMT Company Information
Table 108. Sichuan ZCMT Introduction and Business Overview
Table 109. Sichuan ZCMT Hematology Quality Controls Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 110. Sichuan ZCMT Hematology Quality Controls Product Offerings
Table 111. Sichuan ZCMT Recent Developments
Table 112. Key Raw Materials Lists
Table 113. Key Suppliers of Raw Materials Lists
Table 114. Hematology Quality Controls Downstream Customers
Table 115. Hematology Quality Controls Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Hematology Quality Controls Product Picture
Figure 2. Global Hematology Quality Controls Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 4. Global Hematology Quality Controls Sales Volume (K Units), 2021–2032
Figure 5. Global Hematology Quality Controls Sales Price (US$/Unit), 2021–2032
Figure 6. Hematology Quality Controls Report Years Considered
Figure 7. Global Hematology Quality Controls Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Hematology Quality Controls Sales Volume Ranking of Players (K Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hematology Quality Controls Revenue in 2025
Figure 10. Hematology Quality Controls Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. High Level Picture
Figure 12. Medium Level Picture
Figure 13. Low Level Picture
Figure 14. Global Hematology Quality Controls Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Hematology Quality Controls Sales Value Market Share by Type, 2025 & 2032
Figure 16. Global Hematology Quality Controls Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
Figure 17. Global Hematology Quality Controls Sales Volume Market Share by Type, 2025 & 2032
Figure 18. Global Hematology Quality Controls Price by Type (US$/Unit), 2021–2032
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Laboratory
Figure 21. Global Hematology Quality Controls Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Hematology Quality Controls Sales Value Market Share by Application, 2025 & 2032
Figure 23. Global Hematology Quality Controls Sales Volume by Application (K Units), 2021 vs 2025 vs 2032
Figure 24. Global Hematology Quality Controls Sales Volume Market Share by Application, 2025 & 2032
Figure 25. Global Hematology Quality Controls Price by Application (US$/Unit), 2021–2032
Figure 26. North America Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 27. North America Hematology Quality Controls Sales Value by Country (%), 2025 vs 2032
Figure 28. Europe Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 29. Europe Hematology Quality Controls Sales Value by Country (%), 2025 vs 2032
Figure 30. Asia Pacific Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 31. Asia Pacific Hematology Quality Controls Sales Value by Region (%), 2025 vs 2032
Figure 32. South America Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 33. South America Hematology Quality Controls Sales Value by Country (%), 2025 vs 2032
Figure 34. Middle East & Africa Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 35. Middle East & Africa Hematology Quality Controls Sales Value by Country (%), 2025 vs 2032
Figure 36. Key Countries/Regions Hematology Quality Controls Sales Value (%), 2021–2032
Figure 37. Key Countries/Regions Hematology Quality Controls Sales Volume (%), 2021–2032
Figure 38. United States Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 39. United States Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
Figure 40. United States Hematology Quality Controls Sales Value by Application (%), 2025 vs 2032
Figure 41. Europe Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 42. Europe Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
Figure 43. Europe Hematology Quality Controls Sales Value by Application (%), 2025 vs 2032
Figure 44. China Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 45. China Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
Figure 46. China Hematology Quality Controls Sales Value by Application (%), 2025 vs 2032
Figure 47. Japan Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 48. Japan Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
Figure 49. Japan Hematology Quality Controls Sales Value by Application (%), 2025 vs 2032
Figure 50. South Korea Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 51. South Korea Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
Figure 52. South Korea Hematology Quality Controls Sales Value by Application (%), 2025 vs 2032
Figure 53. Southeast Asia Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 54. Southeast Asia Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
Figure 55. Southeast Asia Hematology Quality Controls Sales Value by Application (%), 2025 vs 2032
Figure 56. India Hematology Quality Controls Sales Value (US$ Million), 2021–2032
Figure 57. India Hematology Quality Controls Sales Value by Type (%), 2025 vs 2032
Figure 58. India Hematology Quality Controls Sales Value by Application (%), 2025 vs 2032
Figure 59. Hematology Quality Controls Industrial Chain
Figure 60. Hematology Quality Controls Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives InterviewedDescription
The global market for Hematology Quality Controls was estimated to be worth US$ 537 million in 2025 and is projected to reach US$ 813 million, growing at a CAGR of 6.2% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hematology Quality Controls cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Hematology Quality Controls are specialized quality control substances used to monitor the stability of the detection process of blood analyzers (such as blood routine testing equipment) and evaluate the performance of the detection system. Its core goal is to ensure that the blood analyzer provides accurate, reliable, and reproducible test results for patient samples at different times, batches of reagents, or operating conditions. It is one of the core tools of the quality management system for blood testing laboratories.
The North American market for Hematology Quality Controls was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Hematology Quality Controls was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Hematology Quality Controls was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Hematology Quality Controls market include Bio-Rad, Streck, Thermo Fisher Scientific, Randox Laboratories, Sysmex, Fortress Diagnostics, Bio-Techne, Diatron, Changchun DIRUI, Shenzhen Mindray, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Hematology Quality Controls, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Hematology Quality Controls market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Hematology Quality Controls.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Hematology Quality Controls manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Hematology Quality Controls sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Hematology Quality Controls sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Related Reports
The global Hematology Quality Controls market is projected to grow from US$ 537 million in 2025 to US$ 770 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Published: 2025-06-13
Pages: 147
USD 4900.00
(Single User License)
The global Hematology Quality Controls market size was US$ 505 million in 2024 and is forecast to a readjusted size of US$ 770 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-06-13
Pages: 100
USD 4250.00
(Single User License)
The global market for Hematology Quality Controls was valued at US$ 505 million in the year 2024 and is projected to reach a revised size of US$ 770 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published: 2025-06-13
Pages: 92
USD 2900.00
(Single User License)
The global market for Hematology Quality Controls was estimated to be worth US$ 505 million in 2024 and is forecast to a readjusted size of US$ 770 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-06-13
Pages: 112
USD 3950.00
(Single User License)
The global Hematology Quality Controls market was valued at US$ 537 million in 2025 and is anticipated to reach US$ 813 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-03-12
Pages: 119
USD 2900.00
(Single User License)
The global Hematology Quality Controls market size was US$ 537 million in 2025 and is forecast to reach a readjusted size of US$ 813 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 97
USD 4250.00
(Single User License)
The global Hematology Quality Controls market is projected to grow from US$ 537 million in 2025 to US$ 813 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 166
USD 4900.00
(Single User License)
The global Hematology Quality Controls market is projected to grow from US$ 537 million in 2025 to US$ 770 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Published: 2025-06-13
Pages: 147
The global Hematology Quality Controls market size was US$ 505 million in 2024 and is forecast to a readjusted size of US$ 770 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-06-13
Pages: 100
The global market for Hematology Quality Controls was valued at US$ 505 million in the year 2024 and is projected to reach a revised size of US$ 770 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published: 2025-06-13
Pages: 92
The global market for Hematology Quality Controls was estimated to be worth US$ 505 million in 2024 and is forecast to a readjusted size of US$ 770 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-06-13
Pages: 112
The global Hematology Quality Controls market was valued at US$ 537 million in 2025 and is anticipated to reach US$ 813 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-03-12
Pages: 119
The global Hematology Quality Controls market size was US$ 537 million in 2025 and is forecast to reach a readjusted size of US$ 813 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 97
The global Hematology Quality Controls market is projected to grow from US$ 537 million in 2025 to US$ 813 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 166
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database